Identificación de genes asociados con Nefropatía Diabética regulados por miRNAs: Análisis In sílico.
Resumen
Referencias
Shen Z, Fang Y, Xing T, Wang F. Diabetic Nephropathy: From Pathophysiology to Treatment. J Diabetes Res. 2017;2379432. DOI: 10.1155/2017/2379432
Colhoun HM, Marcovecchio ML. Biomarkers of diabetic kidney disease. Diabetología. 2018;61(5):996-1011. DOI: 10.1007/s00125-018-4567-5
Staiteieh SA, Akil L, Al Khansa R, Nasr R, Al Sagheer Z, Houshaymi B, Merhi RA. Study of microRNA expression profiling as biomarkers for colorectal cancer patients in Lebanon. Mol Clin Oncol. 2022;16(2):39. DOI: 10.3892/mco.2021.2473
Leitão AL, Enguita FJ. A Structural View of miRNA Biogenesis and Function. Noncoding RNA. 2022;8(1):10. DOI: 10.3390/ncrna8010010
He M, Wang J, Yin Z, Zhao Y, Hou H, Fan J. et al. MiR-320a induces diabetic nephropathy via inhibiting MafB. Aging (Albany NY). 2019;11(10):3055-3079. DOI: 10.18632/aging.101962
Conserva F, Barozzino M, Pesce F, Divella C, Oranger A, Papale M. et al. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy. Sci Rep. 2019;9(1):11357. DOI: 10.1038/s41598-019-47778-1
Pordzik J, Eyileten-Postuła C, Jakubik D, Czajka P, Nowak A, De Rosa S. et al. MiR-126 Is an Independent Predictor of Long-Term All-Cause Mortality in Patients with Type 2 Diabetes Mellitus. J Clin Med. 2021 May 28;10(11):2371. DOI: 10.3390/jcm10112371
Al-Kafaji G, Al-Mahroos G, Al-Muhtaresh HA, Skrypnyk C, Sabry MA, Ramadan AR. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker. Exp Ther Med. 2016;12(2):815-822. DOI: 10.3892/etm.2016.3395
Raitoharju E, Seppälä I, Oksala N, Lyytikäinen LP, Raitakari O, Viikari J, et al. Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: the cardiovascular risk in Young Finns Study. Mol Cell Endocrinol. 2014;391(1-2):41-9. DOI: 10.1016/j.mce.2014.04.013
Lee YJ, Kim V, Muth DC, Witwer KW. Validated MicroRNA Target Databases: An Evaluation. Drug Dev Res. 2015;76(7):389-96. DOI: 10.1002/ddr.21278
Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: An online resource for prediction of microRNA binding sites. PLoS One. 2018;13(10):e0206239. DOI: 10.1371/journal.pone.0206239
Quillet A, Saad C, Ferry G, Anouar Y, Vergne N, Lecroq T. et al. Improving Bioinformatics Prediction of microRNA Targets by Ranks Aggregation. Front Genet. 2020; 10:1330. DOI: 10.3389/fgene.2019.01330
Shved N, Warsow G, Eichinger F, Hoogewijs D, Brandt S, Wild P, et al. Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts. Sci Rep. 2017;7(1):8576. DOI: 10.1038/s41598-017-08492-y
Delrue C, Speeckaert R, Delanghe JR, Speeckaert MM. The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach. Int J Mol Sci. 2022;23(2):807. DOI: 10.3390/ijms23020807
Samsu N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int. 2021;1497449. DOI: 10.1155/2021/1497449.
Tang J, Yao D, Yan H, Chen X, Wang L, Zhan H. The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy. Int J Endocrinol. 2019;8719060 DOI: 10.1155/2019/8719060
Wang Z, Wang Z, Zhou Z, Ren Y. Crucial genes associated with diabetic nephropathy explored by microarray analysis. BMC Nephrol. 2016;17(1):128. DOI: 10.1186/s12882-016-0343-2
Al-Kafaji G, Al-Mahroos G, Al-Muhtaresh HA, Skrypnyk C, Sabry MA, Ramadan AR. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker. Exp Ther Med. 2016;12(2):815-822. DOI: 10.3892/etm.2016.3395
Zhang Y, Chen X, Yuan L, Zhang Y, Wu J, Guo N. et al. Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway. Biochem Biophys Res Commun. 2018 Nov 30;506(3):529-535. DOI: 10.1016/j.bbrc.2018.09.175
Agola JO, Jim PA, Ward HH, Basuray S, Wandinger-Ness A. Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet. 2011;80(4):305-18. DOI: 10.1111/j.1399-0004.2011.01724.x
Ding Y, Tang X, Wang Y, Yu D, Zhu C, Yu J. Tetrandrine alleviates podocyte injury via calcium-dependent calpain-1 signaling blockade. BMC Complement Med Ther. 2021;21(1):296. DOI: 10.1186/s12906-021-03469-x
Guo L, Sanders PW, Woods A, Wu C. The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol. 2001;159(5):1735-42. DOI: 10.1016/S0002-9440(10)63020-9
Meza Letelier CE, San Martín Ojeda CA, Ruiz Provoste JJ, Frugone Zaror CJ. Fisiopatología de la nefropatía diabética: una revisión de la literatura. Medwave. 2017;17(1):e6839. DOI: 10.5867/medwave.2017.01.6839
Du H, Yin Z, Zhao Y, Li H, Dai B, Fan J, et al. miR-320a induces pancreatic β cells dysfunction in diabetes by inhibiting MafF. Mol Ther Nucleic Acids. 2021; 26:444-457. DOI: 10.1016/j.omtn.2021.08.027
Enlaces refback
- No hay ningún enlace refback.